We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWBC icon
526
East-West Bancorp
EWBC
$18.6B
$3.04M 0.03%
84,021
+431
+0.5% +$14.4K
SRCL
527
DELISTED
Stericycle Inc
SRCL
$3.04M 0.03%
54,288
+1,980
+4% +$103K
BF.B icon
528
Brown-Forman Class B
BF.B
$12.9B
$3.04M 0.03%
47,696
+733
+2% +$46.7K
KNX icon
529
Knight Transportation
KNX
$11.9B
$3.03M 0.03%
72,611
+2,085
+3% +$79.5K
ITT icon
530
ITT
ITT
$19.3B
$3.01M 0.03%
51,249
+908
+2% +$48.1K
BC icon
531
Brunswick
BC
$5.27B
$3.01M 0.03%
46,990
+166
+0.4% +$8.27K
NUVA
532
DELISTED
NuVasive, Inc.
NUVA
$3.01M 0.03%
54,034
+2,126
+4% +$123K
DEI icon
533
Douglas Emmett
DEI
$1.99B
$3M 0.03%
97,898
+3,285
+3% +$98.5K
ULTA icon
534
Ulta Beauty
ULTA
$22.2B
$3M 0.03%
14,728
-6
-0% -$1.29K
ZD icon
535
Ziff Davis
ZD
$1.88B
$2.99M 0.03%
54,390
+1,162
+2% +$75.9K
CDK
536
DELISTED
CDK Global, Inc.
CDK
$2.99M 0.03%
72,169
+2,485
+4% +$95.6K
TDY icon
537
Teledyne Technologies
TDY
$31.2B
$2.98M 0.03%
9,590
-11,345
-54% -$3.73M
HAL icon
538
Halliburton
HAL
$27.5B
$2.98M 0.03%
229,440
+3,175
+1% +$34.2K
LECO icon
539
Lincoln Electric
LECO
$15.2B
$2.97M 0.03%
35,267
+167
+0.5% +$13.2K
LPX icon
540
Louisiana-Pacific
LPX
$5.18B
$2.97M 0.03%
115,697
+1,705
+1% +$36.1K
NVR icon
541
NVR
NVR
$17B
$2.95M 0.03%
906
+10
+1% +$30.7K
WES icon
542
Western Midstream Partners
WES
$20.1B
$2.94M 0.03%
293,314
-170,000
-37% -$1.41M
ALE
543
DELISTED
Allete
ALE
$2.93M 0.03%
53,742
+2,118
+4% +$120K
SNX icon
544
TD Synnex
SNX
$20.6B
$2.93M 0.03%
48,910
+2,002
+4% +$93.5K
ANET icon
545
Arista Networks
ANET
$263B
$2.93M 0.03%
223,040
-672
-0.3% -$9.09K
BLKB icon
546
Blackbaud
BLKB
$2B
$2.92M 0.03%
51,222
+2,349
+5% +$129K
WAT icon
547
Waters Corp
WAT
$40.9B
$2.92M 0.03%
16,192
-417
-3% -$78.8K
EXPE icon
548
Expedia Group
EXPE
$38.9B
$2.91M 0.03%
35,427
-594
-2% -$43.2K
VAR
549
DELISTED
Varian Medical Systems, Inc.
VAR
$2.91M 0.03%
23,751
+321
+1% +$37.2K
SIVB
550
DELISTED
SVB Financial Group
SIVB
$2.9M 0.03%
13,473
+181
+1% +$34.9K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.